Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications effect pharmacotherapy attention deficit hyperactivity disorder risk seizures pediatric
… Dyspepsia Gastroesophageal reflux disease (GERD) Pediatric GERD Gastroparesis Gastric cancer Irritable bowel … of GI illnesses. Recent projects have included: Benefit-risk preference studies Cohort and case-control studies … research Reimbursement and value communication strategies Risk management programs including development, …
… identifying appropriate treatment stopping rules, finding publications reporting stratified cost and utility estimates, …
A Cost-Effectiveness Analysis Using Real-World Data William Herring, PhD Director, Health Economics RTI Health Solutions A Cost-Effectiveness Analysis Using Real-World Data from the MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with …
Tailoring Cost-Effectiveness Modeling Methodologies for Multiple Sclerosis Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple …
Willingness-to-Pay Given your product’s treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated using a number of stated-preference methods including discrete-choice experiments and contingent valuation. …
FDA Rare Disease Day 2024 Virtual Public Meeting Share on: Friday, March 1, 2024, 9am - 4:30pm Meeting Agenda & Links We are pleased that Carla (DeMuro) Romano, M.S., Vice President of Patient-Centered Outcomes Assessment at RTI Health Solutions, will be …
Autoimmune Diseases A Wealth of Experience We have collaborated with our clients on projects to research autoimmune diseases, autoimmune treatments, and complications and comorbidities of autoimmune disorders. Our experience includes: Celiac disease …
… with a wide range of data partners, including: Behavioral Risk Factor Surveillance System (BRFSS) CPRD Drug Abuse …
Market Access and Evidence Generation Strategies At every stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s value . For clinical and commercial teams alike, we provide …
Health Economics More than ever, health economic information affects how patients, providers, payers , and regulators make decisions, and we understand your need for credible, reliable, and high-quality evidence-based analyses. Leverage the wide-ranging …